Sources | Names Used |
---|---|
CTRPv2 | navitoclax:birinapant (1:1 mol/mol) |
PharmacoGx | navitoclax:birinapant (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AARS | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AASDHPPT | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ABCC8 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ABCD4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ABCE1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | ABHD14A-ACY1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | ABHD16A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | ABHD17B | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | ABRACL | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | ABTB1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |